Stockreport

Teva gains approval of biosimilar of Amgen's Prolia [Seeking Alpha]

Amgen Inc.  (AMGN) 
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
PDF Prolia is Amgen's best-selling therapy, bringing in ~$4.4B in revenue in 2025. Teva also said that the FDA and the European Fresh Stock Ideas, Every Day More Tren [Read more]